News Categories
Resources For Living
Mesothelioma Forum
Legal Help Blog
Find a Doctor Near You
Mesothelioma Blog
Latest News
- Mesothelin Finding Could Lead to Early Detection of Mesothelioma
- New York Attorney Calls for International Ban on Mesothelioma-Causing Asbestos
- Protein Can be Reliable for Diagnosing Malignant Mesothelioma
- Biomarker Successes Remain Elusive For Mesothelioma and Cancer Researchers
- Avastin May Not be Effective for Breast Cancer, But is Still an Option for Mesothelioma
- Options for Funding Mesothelioma Research
- Golf Outing to Raise Funds for Mesothelioma Research
- 3 Year Mesothelioma Survivor Stays Busy Raising Awareness of the Disease
- MesotheliomaHelp Website Offers Mesothelioma-Related FAQs
- CDMRP System Offers Funding Opportunity to Help Military Mesothelioma Sufferers
Lung Cancer Conference Features Mesothelioma Experts
The American Association for Cancer Research and the International Association for the Study of Lung Cancer are joining forces to sponsor the conference “Molecular Origins of Lung Cancer: Prospects for Personalized Prevention and Therapy.” The conference will be held January 11-14, 2010, at the Loews Coronado Bay Resort in Coronado, California.
The program will focus on the latest in lung cancer research and will feature many speakers from the University of Texas M.D. Anderson Cancer Center known throughout the world for their initiatives in the research and treatment of mesothelioma and their focus on personalized medicine.
Steven M. Albelda, M.D, William Maul Measey Professor of Medicine, Vice Chief, Pulmonary, Allergy, and Critical Care Division Director of Lung Research,Co-Director, Thoracic Oncology Laboratories at University of Pennsylvania Medical Center, whose research focuses on the design of new treatment strategies for lung cancer and mesothelioma will present a session entitled: “Personalizing novel mesothelioma treatments by analyzing interferon response pathways.”
Additional sessions offered include topics covering:
• Early Detection and Prevention
• Drug Design and New Targets
• Cancer Stem Cells
• Genome-wide Approaches to Risk
• Tumor Profiling
• Lung Biomarkers
• Plus a special session on Advocacy, Regulatory, and Funding Issues
© MesotheliomaHelp.Net. All Rights Reserved. Reprinting or republication of this article or any portion of its content is permitted but must include the MesotheliomaHelp.Net link.
Labels: mesothelioma, Research News
posted by Nancy Meredith at 2:00 PM
Link to this article
